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West Nile virus (WNV) is a member of the Flaviviridae family and is transmitted to humans by 
mosquito bites. So far, no vaccine or treatment is available and the only prophylactic strategies 
consist of preventing mosquito bites by using insect repellents or wearing protective clothing. The 
outcome of the infection is variable: while most people do not manifest any symptoms, about 1 in 5 
develop a fever and of these, 1% has a severe, sometimes fatal, neurologic illness characterized by 
encephalitis, meningitis and acute flaccid paralysis. 
Limited knowledge is available on the immune response to WNV in humans due to the high 
prevalence of non-symptomatic cases. Although several studies have been performed on inbred B6 
mice, the infection in this model is less informative because it lacks the genetic diversity observed in 
humans. 
A collaborative effort between Fred Hutch, University of Washington, University of North Carolina at 
Chapel Hill and Emory University led to the generation of a new model to study the immune 
response to WNV infection, the Collaborative Cross (CC) mouse. The CC model was obtained by 
crossing eight different mouse strains, including 5 classical inbred strains and 3 wild type derived 
strains. Recombinant inbred strains were generated by three generation of funnel breeding followed 
by at least 20 generation of inbred mating to develop each line. 
Researchers Jessica Graham and Jessica Swarts from Jennifer Lund's Laboratory (Vaccine and 
Infectious Disease Division), together with their collaborators, investigated the effects of WNV 
infection on different CC strains and reported their results last month on the journal mBio. 
Their results showed that the model was closer to ideal based on its ability to recapitulate the 
variability of the human disease outcome. First, three different disease phenotypes were observed: 
asymptomatic, symptomatic and asymptomatic with central nervous system (CNS) involvement. 
Asymptomatic mice did not show clinical signs, the ones with CNS involvement had inflammatory 
infiltrates in the brain, and symptomatic mice showed severe clinical scores and weight loss starting 
at day 7 after infection. Early innate immune responses, estimated by the expression of interferon 
beta and IFIT1, a molecule modulated by type I interferons, were associated with a better outcome.  
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In fact, while in asymptomatic mice the two genes were up-regulated at early time points and then 
decreased, in symptomatic mice they remained elevated at later time points as a possible 
consequence of the lack of viral control. A more complex situation was observed in the adaptive 
immune responses. While WNV-specific IgM and T cells increased at early time points to then 
decrease after the infection was cleared from the periphery in asymptomatic mice, the symptomatic 
strains showed diverse responses. 
Finally, the researchers addressed the genetic variability of the CC mice by evaluating the 
relationship between two different allele classes and disease outcome for the gene Oas1b, encoding 
a protein with known antiviral function. The researchers showed that strains homozygous for the 
classical inbred allele had an enhanced propensity for a symptomatic disease outcome, while the 
wild-type allele was correlated with a symptomatic disease outcome. 
"The CC model allows us to link rare outcomes with host genotype to identify genes of susceptibility 
and protection from WNV infection and disease," explains Dr. Graham. "This can assist us in 
identifying unique correlates of protection from neuroinvasive viral infections to inform therapeutic 
and vaccine strategies for controlling WNV infection in humans." In sum, the new CC mouse model 
better recapitulate the variety of WNV infection outcomes observed in humans: do we have a new, 
better model for infectious disease research? 
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Image provided by Ms. Jessica Swarts 
Schematics representing the generation of the genetic diversity in the CC 
mouse model. 
 
